Atlas Trials

A Phase II Study of SHR2554 in Patients With Relapsed or Refractory Follicular Lymphoma

Clinical trial NCT06368167 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06368167
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Follicular Lymphoma
Start date
2024-04-01
Primary completion
2027-04-01
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.